Kaitlin M. Kestenberg Messina Adma Biologics, Inc. (ADMA) insider trading activity

Kaitlin M. Kestenberg Messina is COO and SVP, Compliance of ADMA BIOLOGICS, INC.. Currently has a direct ownership of 488,690 shares of ADMA, which is worth approximately $7.48 Million. The most recent transaction as insider was on Jul 30, 2025, when has been sold 1,208 shares (Common Stock) at a price of $18.59 per share, resulting in proceeds of $22,456. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 489K

0.35% 3M change

8.82% 12M change

Total Value Held $7.48 Million

Kaitlin M. Kestenberg-Messina Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 30 2025	SELL Payment of exercise price or tax liability	$22,456 $18.59 p/Share	1,208 Reduced 0.25%	488,690 Common Stock
Jul 30 2025	BUY Exercise of conversion of derivative security	$22,450 $8.98 p/Share	2,500 Added 0.51%	489,898 Common Stock
Jul 24 2025	SELL Payment of exercise price or tax liability	$52,397 $17.31 p/Share	3,027 Reduced 0.62%	487,398 Common Stock
Apr 01 2025	SELL Payment of exercise price or tax liability	$367,426 $19.42 p/Share	18,920 Reduced 3.71%	490,425 Common Stock
Mar 07 2025	SELL Payment of exercise price or tax liability	$66,973 $17.02 p/Share	3,935 Reduced 0.77%	509,345 Common Stock
Mar 06 2025	SELL Payment of exercise price or tax liability	$150,177 $16.91 p/Share	8,881 Reduced 1.7%	513,280 Common Stock
Feb 25 2025	SELL Payment of exercise price or tax liability	$28,641 $15.44 p/Share	1,855 Reduced 0.35%	522,161 Common Stock
Feb 19 2025	BUY Grant, award, or other acquisition	-	77,784 Added 12.93%	524,016 Common Stock
Jan 30 2025	SELL Payment of exercise price or tax liability	$54,015 $16.1 p/Share	3,355 Reduced 0.75%	446,232 Common Stock
Jan 30 2025	BUY Exercise of conversion of derivative security	$54,000 $10.8 p/Share	5,000 Added 1.1%	449,587 Common Stock
Dec 31 2024	SELL Payment of exercise price or tax liability	$31,796 $17.15 p/Share	1,854 Reduced 0.42%	444,587 Common Stock
Sep 30 2024	SELL Payment of exercise price or tax liability	$52,913 $19.99 p/Share	2,647 Reduced 0.59%	446,441 Common Stock
Aug 30 2024	SELL Open market or private sale	$408,134 $16.9 p/Share	24,150 Reduced 5.1%	449,088 Common Stock
Aug 30 2024	BUY Exercise of conversion of derivative security	$94,185 $3.9 p/Share	24,150 Added 4.86%	473,238 Common Stock
Jul 24 2024	SELL Payment of exercise price or tax liability	$33,977 $13.58 p/Share	2,502 Reduced 0.55%	449,088 Common Stock
Jun 30 2024	SELL Payment of exercise price or tax liability	$23,310 $11.18 p/Share	2,085 Reduced 0.46%	451,590 Common Stock
Apr 01 2024	BUY Grant, award, or other acquisition	-	192,320 Added 38.71%	304,510 Common Stock
Mar 31 2024	SELL Payment of exercise price or tax liability	$13,761 $6.6 p/Share	2,085 Reduced 1.82%	112,190 Common Stock

KMK

Kaitlin M. Kestenberg Messina

COO and SVP, Compliance

Boca Raton, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADMA shares.

Notify only if

Value

Insider Trading

Get notified when an Adma Biologics, Inc. insider buys or sells ADMA shares.

Notify only if

Operation

Value

Type

News

Receive news related to ADMA BIOLOGICS, INC.

Track Activities on ADMA

Account